Austin's XBiotech Collabotes With European Medicines Agency (EMA) on Phase …

Published February 8, 2014

Austin's XBiotech Collabotes With European Medicines Agency (EMA) On Phase …
XBiotech AG, the company's European base of operations, is planning to launch its Phase III registration study in Europe for Xilonix to test the drug's effectiveness in treatment-resistant colorectal cancer. The study is currently set to include cancer …
Read more on BioNews Texas

Creatine Transporter Deficiency Treatment By Lumos Pharma To Enter Testing …
Austin-based startup biopharmaceutical company Lumos Pharma, a drug developer specifically targeting solutions for Rare and Neglected Diseases, announced today that a new Series A financing initiative has netted the company $ 14 million in fresh funding …
Read more on BioNews Texas

More Austin Texas Drug Treatment Centers Information…